# Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fed Condition

> **NCT01603186** · PHASE1 · COMPLETED · sponsor: **IPCA Laboratories Ltd.** · enrollment: 54 (actual)

## Conditions studied

- Fed

## Interventions

- **DRUG:** Quetiapine Fumarate Tablets 25 mg
- **DRUG:** Quetiapine Fumarate

## Key facts

- **NCT ID:** NCT01603186
- **Lead sponsor:** IPCA Laboratories Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2012-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01603186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01603186, "Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fed Condition". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01603186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*